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Background:  Depression  is one  of the  most  frequently  reported  psychological  problems  following  TBI,
however  prevalence  estimates  vary  widely.  Methodological  and  sampling  differences  may  explain  some
of this  variability,  but  it is  not  known  to what  extent.
Methods: Data  from  99  studies  examining  the  prevalence  of  clinically  diagnosed  depression  (MDD/
dysthymia)  and  self-reports  of  depression  (clinically  signiﬁcant  cases  or  depression  scale  scores)  fol-
lowing  adult,  non-penetrating  TBI were  analysed,  taking  into  consideration  diagnostic  criteria,  measure,
post-injury  interval,  and  injury  severity.
Results:  Overall,  27%  of  people  were  diagnosed  with  MDD/dysthymia  following  TBI and  38%  reported  clini-
cally  signiﬁcant  levels  of  depression  when  assessed  with  self-report  scales.  Estimates  of  MDD/dysthymia
varied  according  to  diagnostic  criteria  (ICD-10:  14%;  DSM-IV:  25%;  DSM-III:  47%)  and  injury  severity
(mild:  16%;  severe:  30%).  When  self-report  measures  were  used,  the  prevalence  of clinically  signiﬁcantdult
elf-report measures
njury severity
ost-injury interval
cases  of  depression  differed  between  scales  (HADS:  32%;  CES-D:  48%)  method  of administration  (phone:
26%; mail  46%),  post-injury  interval  (range:  33–42%),  and  injury  severity  (mild:  64%;  severe:  39%).
Conclusion:  Depression  is very  common  after  TBI and  has  the  potential  to impact  on  recovery  and  quality
of  life.  However,  the diagnostic  criteria,  measure,  time  post-injury  and  injury  severity,  all  impact  on
prevalence  rates  and  must  therefore  be  considered  for benchmarking  purposes.
Crown  Copyright  © 2014  Published  by  Elsevier  Ltd. This  is  an  open  access  article  under  the CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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. Introduction
Traumatic brain injuries (TBIs) can cause a variety of changes
n cognitive, physical and psychological functioning, which may
mpact on all areas of a person’s life. Cognitive changes include
roblems with memory and attention, poorer executive function-
ng and slowed information processing (Bay et al., 2012; Belmont
t al., 2009; Konrad et al., 2011; Rochat et al., 2009), with the physi-
al consequences including headaches, sleep problems and fatigue
Cantor et al., 2012; Chaput et al., 2009; Mathias and Alvaro, 2012).
sychological problems are also very common following TBI (for a
eview see Kim et al., 2007), with the most widely recognised and
esearched of these being depression (Hart et al., 2012; Rapoport,
012).
The prevailing biopsychosocial model of health provides one
ramework for understanding some of the variables that may
ontribute to the development of these problems – including
epression – following TBI (Helmchen, 2013). Speciﬁcally, this
odel posits that illnesses are caused by a complex interaction
etween a range of biological, psychological and social factors,
ith a person’s vulnerability to illness changing over time (Molina,
983). In the context of TBI, there are a variety of neuroanatomical
hanges that may  provide a biological basis for the development
f depression. For example, the shear, tensile and compressive
trains experienced during a TBI can lead to diffuse axonal injury
n the frontal and temporal lobes, disrupting the neural circuitry
etween the prefrontal cortex, amygdala, hippocampus, basal gan-
lia and thalamus (Jorge and Robinson, 2002; Kumar and Cook,
002; Morris, 2010; Silver et al., 2009). This neuronal damage and
ell loss can occur for weeks to months after an injury, and may
rovide the neurological substrate for many of the cognitive and
sychological changes that occur after a TBI (Jorge and Starkstein,
005; Sherin and Nemeroff, 2011). Neurochemical changes, such
s cholinergic and serotonergic deﬁcits, neuroendocrinal abnor-
alities and compromised hypothalamic–pituitary–adrenal axis
unction, also occur in the acute period post-TBI; potentially also
ausing depression (Jorge and Starkstein, 2005; Rosenthal et al.,
998). Psychological variables – such as a diminished tolerance
o frustration, impaired self-awareness, low self-esteem, and poor
oping strategies – may  additionally lead to depression after a TBI
Kelley et al., 2012; Malec et al., 2007; Molina, 1983). Lastly, a
ariety of social factors – including a lack of social support, the
oss of personal relationships/friendships, unrealistic expectations
nd involvement in litigation – may  independently contribute to
he development of depression following TBI or exacerbate symp-
oms that arise from any of the aforementioned causes (Dikmen
t al., 2003; Gunstad and Suhr, 2001; Iverson et al., 2010b;
aljas et al., 2014). Thus, there are a large number of variables
hat may  explain why depression is a common problem after
BI.
Estimates of the prevalence of depression following TBI vary
onsiderably – ranging from 6% to 77% (Rutherford et al., 1977;
arney et al., 1987). This variability not only seriously limits the
linical utility of these ﬁndings, but also raises questions about
ts source. Differences in how depression is conceptualised (diag-
osed disorder vs self-reported symptoms), the diagnostic criteria
nd/or measures that are used to assess depression and a number of
atient characteristics (e.g., injury severity), may  explain a signiﬁ-
ant amount of this variance; however, we do not currently know to . . . .  .  . .  . . . . . .  . . . . .  . .  .  . . . . . .  .  . . . . . . .  .  . . .  . . . .  . .  .  .  . . . .  .  .  . . . . .  . . .  .  .  .  . . . .  .  . . . . .  13
what extent these variables impact on estimates of the prevalence
of depression following TBI.
The two most commonly diagnosed depressive disorders fol-
lowing TBI are major depressive disorder (MDD) and dysthymia
(Gomez-Hernandez et al., 1997; Hibbard et al., 1998; Meares
et al., 2011; Whelan-Goodinson et al., 2009a), which are gener-
ally determined using one of two criteria, namely the Diagnostic
and Statistical Manual of Mental Disorders (DSM-III, DSM-IV, DSM-
5; American Psychiatric Association [APA], 1987, 2001, 2013) or
the International Classiﬁcation of Diseases (ICD-9, ICD-10; World
Health Organisation, 1977, 1992). These disorders have overlapping
symptoms, including depressed mood, disturbed sleep, low energy
and poor concentration. Whereas a diagnosis of MDD  requires the
presence of ﬁve or more symptoms during a 2-week period, dys-
thymia (also known as persistent depressive disorder) requires the
presence of two  symptoms for a minimum of 2 years (APA, 2013).
MDD and dysthymia are frequently diagnosed using one of a
number of structured clinical interviews to determine whether
their patients meet DSM or ICD criteria (e.g., Structured Clinical
Interview for DSM-IV Axis I Disorders [SCID-I]; First et al., 1997).
However, these interviews examine symptoms over different time
periods – ranging from the previous week (e.g., the Clinical Inter-
view Schedule [CIS]; Lewis et al., 1992) to the previous month
(e.g., SCID, Schedules for Clinical Assessment in Neuropsychia-
try [SCAN]; Wing et al., 1990) or preceding 6 months/year (e.g.,
Composite International Diagnostic Interview [CIDI]; Robins et al.,
1988); which may  have a signiﬁcant impact on the resulting preva-
lence rates. Not only can the symptoms vary between these time
frames, but also memory and other cognitive problems following
TBI may  affect the accuracy of the information that is reported
(Hilsabeck et al., 1998). Therefore, differences in the diagnostic
criteria and/or interview schedules that are used may  be impacting
on estimates of the prevalence of MDD  and dysthymia.
Prevalence rates may  additionally be affected by a number
of sample characteristics, including the time interval between
the injury and when depression is assessed. Some studies have
found that MDD  is more prevalent in the early stages after an
injury (Bombardier et al., 2010; Lin et al., 2010), possibly reﬂecting
neuroanatomical abnormalities or the cascade of neurochemical
changes that occur in the acute post-TBI period (Jorge et al., 1993a).
Conversely, others have found MDD  and/or dysthymia are more
common in the long-term (Al-Adawi et al., 2007; Rao et al., 2010),
which may  be more indicative of the psychosocial challenges faced
by individuals as they adjust to their altered life circumstances
(e.g., lack of social support, reduced social functioning) (Jorge et al.,
1993b). Similarly, the severity of an injury can range from minor to
severe, with some studies examining mixed samples (mild, mod-
erate and severe), others targeting speciﬁc injuries (e.g., mild or
severe), and still others examining less common categories, such
as minor (Van Der Horn et al., 2013) or complicated mild TBI
(Bombardier et al., 2010; Fann et al., 2005; Juengst et al., 2013).
In addition, control groups are often also recruited to examine
the base-rates of depression because depression is not unique to
TBI, but the samples chosen for this purpose can vary. Typically,
medical patients (Brown et al., 2004; Jorge et al., 2004), people from
the general community (Belmont et al., 2009; Konrad et al., 2011;
Ponsford and Ziino, 2003), or family and friends of the TBI group
(Perlesz et al., 2000; Ponsford et al., 2003) are used for this purpose.
Each one attempts to control for the potential impact of different
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ariables (e.g., illness-related stress) on the prevalence of depres-
ion and, therefore, the base-rates are likely to differ between these
roups. Once again, it is not known whether or how the choice of
ontrol groups impacts on the conclusions that are drawn regarding
ost-TBI rates of depression when they are used for comparative
urposes.
Also important is the distinction between clinical diagnoses of
DD/dysthymia and assessments that use self-report question-
aires (e.g., Beck Depression Inventory [BDI]; Beck et al., 1996) to
ssess depression on a continuous scale (minimal to severe); often
ith the additional ability to identify clinically-signiﬁcant levels of
epression (‘cases’) using designated cut-off scores (dichotomous
cale). Self-report scales are frequently used in clinical settings to
creen for depression and in research settings to examine the preva-
ence and severity of depression following TBI. However, many of
hese scales were not speciﬁcally designed for use with TBI groups
r in medical settings; instead being intended for use with the
eneral population (e.g., Center for Epidemiological Scale – Depres-
ion [CES-D]; Radloff, 1977) or psychiatric patients (e.g., Hamilton
epression Rating Scale [HAM-D]; Hamilton, 1960). Consequently,
hey may  contain items that can be affected by the physical con-
equences of a TBI (e.g., poor sleep, fatigue), which may  inﬂate the
revalence of depression.
Furthermore, the way that clinicians or researchers administer
uestionnaires may  affect the depression scores obtained on self-
eport scales. Various administration methods have been used, with
ome participants completing them at the research site (Hudak
t al., 2011; Konrad et al., 2011), in their own home (Bushnik et al.,
008; King and Kirwilliam, 2011), over the phone (Bombardier
t al., 2010; Hart et al., 2011) or by using a combination of these
ethods (Hawthorne et al., 2009; Smith, 1992). Speciﬁcally, certain
ituations may  elicit socially-desirable responses, provide fewer
pportunities to reﬂect on and revise answers (e.g., telephone inter-
iews), or be subject to other unidentiﬁed inﬂuences (e.g., mailed:
hen completed and whether completed alone/with others). These
ariables are known to have an impact on people’s responses (for
 review see Richman et al., 1999) and, consequently, should be
onsidered in the current context.
Any one or more of these variables has the capacity to inﬂuence
stimates of the prevalence of depression and may  help to explain
hy the aforementioned statistics vary so widely. However, as yet,
heir impact has not been assessed. A systematic analysis of the
revalence of depression following TBI is needed to evaluate the
mpact of these variables and to assist clinicians in selecting the
ost appropriate benchmark(s) for their particular circumstance.
he current study therefore meta-analysed existing research that
as examined: (1) the prevalence of clinical diagnoses of MDD  and
ysthymia following TBI or (2) used self-report scales to assess the
revalence of clinically signiﬁcant symptoms and/or the severity of
epression. To this end, the impact of diagnostic criteria, interview
chedule, post-injury interval and injury severity on the prevalence
f MDD/dysthymia was  evaluated, as was the type of control group.
n addition, the impact of questionnaire, method of administration,
ost-injury interval, injury severity and type of control group on
elf-reported measures of depression was examined.
. Methods
.1. Literature search, inclusion and exclusion criteria
Comprehensive searches of the PsycINFO, Pubmed, Scopus,
nd ISI Web  of Knowledge electronic databases, from January
980 to June 2013, were undertaken to identify studies that
xamined depression following TBI using search terms that were
ailored for each database (see Supplementary data: Table A). Inehavioral Reviews 47 (2014) 1–15 3
addition, the reference lists of all studies that were included in
the ﬁnal analysis were examined to identify any other relevant
research.
For a study to be included in the current meta-analysis, it had
to meet the following criteria: (1) it examined depression follow-
ing non-penetrating TBI; (2) participants were 18 years or older
(where age range was not provided: mean age minus 1 SD ≥18); (3)
it reported the prevalence of current MDD  or dysthymia, which was
formally diagnosed using DSM or ICD criteria, and/or ‘cases’ (clin-
ically signiﬁcant levels of depression), or depression scale scores
from a common self-report depression scale (excludes general
quality of life and mood-state measures, and study-speciﬁc or mod-
iﬁed scales) (see Supplementary data: Table B for a list of eligible
measures); (4) data were provided for a TBI sample (single-sample)
or both a TBI and control group (independent samples); (5) the
data (prevalence rates, cases or depression scores) were reported
in a way that enabled the calculation of an effect size; (6) the data
were published in a journal in English and contained original data
(excludes reviews); and (7) the sample size was greater than 15
(excludes very small samples and case studies).
Studies were excluded if participants were drawn exclusively
from very speciﬁc or at-risk TBI populations – such as war  vet-
erans, prison inmates, victims of large-scale trauma/terrorism, or
psychiatric populations – as their exposure to other traumatic
events/situations may  have increased their vulnerability to depres-
sion, rendering them less comparable to the broader TBI population.
In addition, control groups were excluded if the group was very
speciﬁc (e.g., depressed controls), depression was not assessed, or
different depression scales were administered to the TBI and con-
trol groups. Moreover, if a study examined the efﬁcacy of some form
of treatment, only the pre-treatment data were analysed.
The literature search initially identiﬁed 8,399 potentially rel-
evant articles, 2,217 of which were duplicates. The titles and
abstracts of the remaining 6,182 articles were screened by the
ﬁrst author (AJO) using the aforementioned inclusion and exclu-
sion criteria, after which the full-text versions of 459 studies were
retrieved for detailed screening. Re-application of the inclusion
criteria to these papers reduced the number of eligible studies to
99 (see Supplementary data: Table C for an overview of the study
review and selection process). In ambiguous cases, papers were
independently assessed by AJO and JLM, and eligibility determined
following discussion.
Data that are meta-analysed must be obtained from indepen-
dent samples (Rosenthal, 1995); consequently all studies were
checked to establish independence. Six samples were followed lon-
gitudinally (two articles each); the data from these articles were
combined, resulting in six independent studies; further reducing
the ﬁnal number of eligible studies to 93. Moreover, the data for
the control groups from ﬁve studies were unsuitable for present
purposes: only the TBI data from these studies were extracted
(Capizzano et al., 2010; Hawthorne et al., 2009; Reza et al., 2007;
Schnabel and Kydd, 2012; Wood and Williams, 2008).
2.2. Data preparation
Some basic data preparation was needed in order to render it
suitable for analysis. Speciﬁcally, where demographic details were
reported for TBI subgroups that were not relevant to the current
analyses (e.g., fatigued vs non-fatigued TBI patients), the data were
combined. If median and range were reported (e.g., age), the mean
and SD were estimated using the methods recommended by Hozo
et al. (2005). In addition, where necessary, standard errors were
transformed to standard deviations and descriptive data trans-
formed to a common scale of measurement (e.g., time-since-injury:
months).
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The post-injury interval for studies varied widely – ranging
rom a few days to over 30 years – necessitating the classiﬁcation
f these intervals into four broad groups: the ﬁrst included studies
hat examined mean post-injury intervals of <6 months (acute to
ost-acute period); the second included intervals of ≥6 months
o <2 years (short term); the third spanned ≥2 years to <5 years
medium term); and the fourth ≥5 years (long-term). Unfortu-
ately, very few studies reported separate prevalence rates for
heir mild, moderate and severe participants. Thus, the data from
tudies that examined mild-moderate and moderate–severe TBI
amples were combined with those that assessed all three cate-
ories (mild, moderate and severe) for present purposes. Further,
here studies assessed depression in a control group, the type
f control was classiﬁed into one of three groups: ‘medical con-
rols’ (spinal cord, orthopaedic or general trauma patients),
general community’, or ‘signiﬁcant other’ (family/friends/
aregivers).
.3. Data collection and effect size calculation
Demographic and injury information (e.g., age, gender, time-
ince-injury, injury severity data), the method by which depression
as assessed (e.g., clinical diagnosis of MDD/dysthymia or self-
eport measure), the criteria used to diagnose MDD/dysthymia
e.g., DSM-IV, ICD-10), the measure used (clinical diagnoses: SCID-I,
CAN, etc., self-report: BDI, Hospital Anxiety and Depression Scale
HADS], etc.), the method by which self-report scales were admin-
stered (research centre, phone, mail, or combination of methods),
ample details (i.e., recruitment source, pre-injury history of mental
ealth problems and TBIs, current medication use, type of control
roup [medical, community, signiﬁcant other]), and statistical data
ecessary for the calculation of effect sizes were extracted from
ach study for analysis. This information was then entered into
omprehensive Meta-Analysis Software version 2 (CMA; ©2006,
iostat, Inc., Englewood, NJ, USA).
Three types of effect size were calculated in the current study.
irstly, proportions were used to summarise the prevalence of (1)
linically diagnosed cases of MDD  and dysthymia, and (2) clin-
cally signiﬁcant levels of depression, based on self-report data
‘cases’), in studies that used single (TBI) or independent (TBI and
ontrols) samples designs. Weighted mean prevalence rates were
alculated using sample size as the weighting variable. Secondly,
dds ratios were calculated to measure any increase (OR >1) or
ecrease (OR <1) in the likelihood of experiencing depression fol-
owing TBI for those studies that used self-report measures to
dentify clinically signiﬁcant levels of depression (cases) in TBI
nd control groups. Thirdly, weighted standardised mean differ-
nces (Hedges g) were used to estimate the magnitude of the
ifference between the depression scale scores (means, SDs) of TBI
nd Control groups (independent samples study design). A posi-
ive Hedges g indicates that the TBI group reported higher levels
f depression than the controls, with a small effect deﬁned as
.2, a moderate effect as ≥.5, and a large effect as ≥.8 (Cohen,
992). As a guide, a Hedges g of .5 (medium effect) indicates that
he means of the two groups differ by half of a pooled standard
eviation.
The current study used a conservative random-effects model
o calculate effect sizes, which assumes that effect sizes can vary
ue to sampling error and differences in study design. Importantly,
hen a study reported multiple scores that were eligible to be
ncluded in the same analysis, a mean effect was  calculated to
nsure that each study only contributed one effect size to any given
nalysis (Lipsey and Wilson, 2001). Forest plots were generated
o examine the effect size distributions and assist in identifying
utliers (Boyles et al., 2011), and ninety-ﬁve percent conﬁdence
ntervals (95% CIs) were calculated to provide the upper and lowerehavioral Reviews 47 (2014) 1–15
bounds within which we can be 95% conﬁdent that the actual pop-
ulation prevalence rate for depression following TBI lies. In the case
of Hedges g, 95% CIs do that do not include zero, indicate that there
is a signiﬁcant difference between the depression scores of the TBI
and control groups.
One problem that meta-analyses face is that the research lit-
erature may  be biased towards publishing studies that report
signiﬁcant ﬁndings (publication bias/ﬁle-drawer problem) and,
consequently, the resultant analyses tend to exclude non-
signiﬁcant ﬁndings; thereby inﬂating the effect sizes (Rosenthal,
1979). Publication bias was  assessed using Orwin’s (1983) Fail-
safe N statistic (Nfs), which estimates the number of unpublished
studies that would be required to draw a ﬁnding into question.
Orwin’s formula requires three values to compute a Nfs: the num-
ber of studies contributing to a mean effect, the resulting weighted
mean effect size, and an alternative mean effect size, below which
a result would be considered inconsequential/of minor clinical sig-
niﬁcance. For current purposes, TBI prevalence rates of less than
7.5%, odds ratios of <1.0, and Hedges g values of <0.15 were deemed
to be of minor clinical signiﬁcance. These ﬁgures were chosen
on the basis of (a) a population-based survey of the 12-month
prevalence of depression in Australian adults (Australian Bureau of
Statistics, 2008), (b) Hopkin’s (2002) guidelines for a trivial effect
when using odds ratios, and (c) Cohen’s deﬁnition of a small stan-
dardised mean difference. The resulting Nfs indicates the number
of unpublished studies, with non-signiﬁcant ﬁndings, that would
be required to render the current ﬁndings inconsequential. There-
fore, the larger the Nfs, the more conﬁdence we can have in a
ﬁnding.
2.4. Statistical analyses
Consistent with recommendations made by the Meta-Analysis
of Observational Studies in Epidemiology (MOOSE) group Stroup
et al. (2000), the impact of a variety of methodological and samp-
ling variables on ﬁndings were examined in order to address the
fact that ﬁndings from different studies were heterogeneous. This
approach is also suggested by Borenstein et al. (2009) who note
that a random-effects model and subgroup analyses can be used to
identify sources of variability in the data.
The overall prevalence of MDD  and dysthymia was calculated
on the basis of data extracted from studies that used a single-
sample (TBI group) or independent samples (TBI + controls) design,
after which the impact of a number of moderator variables on the
prevalence of MDD  and dysthymia was  examined, namely the:
diagnostic criteria (DSM-III, DSM-IV, ICD-10); clinical interview
(SCID-I, SCAN, etc.); time post-injury (<6 months, ≥6 months to
<2 years, ≥2 years to <5 years, ≥5 years); and injury severity (i.e.,
mild, mild–moderate–severe, severe). In addition, the prevalence
of MDD  and dysthymia, relative to controls, was examined using
ORs; both overall and based on the type of control group (medical,
community, signiﬁcant other).
Next, studies that used self-report scales to identify clinically
signiﬁcant levels of depression were examined. The overall preva-
lence of depression (cases) was  calculated using data from single
and independent samples designs, and the following moderator
variables examined: the self-report scale (BDI, HADS, etc.); the
method of administration (research centre, phone, mail, or com-
bination of methods); time post-injury; and injury severity. The
prevalence of clinically signiﬁcant levels of depression (cases), rel-
ative to controls, was  examined using ORs – both overall and
by type of control group. Finally, the depression scale scores of
TBI and control groups (level/severity of depression) were com-
pared using Hedges g – both overall and by type of control
group.
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Table  1
Summary demographic and injury characteristics for the studies (N = 93).
Variable Nstudies Nparticipants % Mean SD
Sample size 93 11,926 131 209
Age  (years) 93 11,926 37.1 6.8
Gender (males) 93 8,176 68.6
Time-since-injury (months) 92 11,898 33.7 51.7
Glasgow Coma Scale score (GCS) 32 4,037 9.7 2.2
Injury  severity
Mild 12 1,134 9.5
Mild, moderate 8 912 7.6
Mild, moderate, severe 46 6,779 56.8
Moderate, severe 17 2,569 21.5
Severe 8 415 3.8
Details not speciﬁed 2 117 0.9
Recruitment source
Outpatients 84 10,815 90.7
Inpatients 6 936 7.8
Both  3 175 1.5
Pre-injury history of depression or anxiety
Participants with history included 38 5,784 48.5
Participants with history excluded 15 1,881 15.8
Not  speciﬁed 40 4,261 35.7
Pre-injury history of TBI
History of prior TBI 12 1,146 9.6
No  history of prior TBI 21 2,051 17.2
Not  speciﬁed 60 8,729 73.2
Treatments
Depression/anxiety medication 11 1,180 9.9
Anti-epileptic medication 2 138 1.2
Medication or counselling 1 100 0.8
Participants excluded if using medication 2 73 0.6
Medications used, no further detail 2 152 1.3
Not  speciﬁed 75 10,283 86.2
NStudies NTBI % NControl %
Type of control group
Medical 11 1,077 42.5 1,067 44.6
General community 13 809 31.9 691 28.9
Signiﬁcant others 7 647 25.5 633 26.5
Total  31 2,533 2,391
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pote: Nstudies and Nparticipants refer to the total number of studies and participants for
edical (Clarke et al., 2012).
. Results
.1. Participant details
The 93 studies included in this meta-analysis provided data for
 total of 11,926 participants. The background demographic and
njury data for these studies are summarised in Table 1, where it
an be seen that the majority of participants were young to middle-
ged males.
Most studies reported the mean time between injury and assess-
ent (Nstudies = 92), with the average interval being just under 3
ears (see Table 1). In contrast, only a limited number of stud-
es reported mean Glasgow Coma Scale scores (GCS) (Nstudies = 32),
lthough most provided categorical information relating to injury
everity. The majority of studies examined mixed samples of mild,
oderate and severe TBI (Nstudies = 46), however most did not
eport separate outcomes for these sub-groups.
Participants were largely recruited from outpatient settings
Nstudies = 84; see Table 1). Six studies recruited from inpatient sett-
ngs, all of which examined depression 1–6 months after severe
BI. Thirty-eight studies included participants who had a pre-injury
iagnosis of depression or anxiety (779 out of 5,784 participants),
5 excluded participants on this basis, and 40 did not specify.
lthough the majority of studies failed to report whether partic-
pants had previously sustained a TBI (Nstudies = 60) or excluded
articipants with such a history (Nstudies = 21), 12 studies reported data were available. One study used two different control groups: community and
that 167 of their 1,146 participants had previously sustained a
TBI. Similarly, most studies (Nstudies = 75) failed to report medica-
tion use, however 11 reported that 314 (out of 1,180) participants
were taking medications for depression or anxiety. Finally, 30 stud-
ies recruited one or more control groups (see Table 1), with the
majority using medical (Nstudies = 11; primarily general trauma) or
community (Nstudies = 13) controls, and a further seven recruiting
signiﬁcant others (family, friends, caregivers of the TBI group).
3.2. Prevalence of formally diagnosed depression following TBI
The data from all studies that reported the prevalence of MDD
and/or dysthymia following TBI (Nstudies = 31, Nparticipants = 5,678)
were combined in order to calculate an overall prevalence rate.
Fig. 1a
provides a forest plot of the prevalence rates for each of the
individual studies (rank-ordered by size), together with the overall
weighted mean, which indicates that, on average, 27% were diag-
nosed with MDD  or dysthymia after a TBI. The associated Nfs was
very large (Nfs = 81), suggesting that publication bias is unlikely to
be a problem. Importantly, there was substantial variation in the
prevalence estimates of individual studies (range: 9–67%), high-
lighting the need to undertake additional analyses to examine some
of the variables that may  have contributed to this variability.
Studies were ﬁrst partitioned according to the diagnostic crite-
ria that were used and, as seen in Fig. 1b, most used DSM criteria.
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Fig. 1. Prevalence of formally diagnosed MDD and dysthymia: (a) overall, (b) diagnostic criteria, (c) interview schedule, (d) time post-injury, (e) injury severity, (f) overall,
relative  to controls, and (g) according to the type of control group. Note: MDD, major depressive disorder; CI, conﬁdence interval; Nfs, fail-safe N; ICD, International Classiﬁcation
of  Diseases; DSM, Diagnostic and Statistical Manual; MINI, Mini-International Neuropsychiatric Interview; SCAN, Schedules Clinical Assessment in Neuropsychiatry; SCID,
Structured Clinical Interview; PSE, Present State Examination; PHQ-9, Patient Health Questionnaire-9; CIDI, Composite International Diagnostic Interview; SADS-L, Schedule
for  Affective Disorders and Schizophrenia (lifetime); DIS, Diagnostic Interview Schedule; NFI, Neurobehavioral Functioning Inventory; CIS, Clinical Interview Schedule. Refer
online  Supplementary data: Table D for details of studies contributing to the summary analyses in this ﬁgure; Kreutzer et al., 2001 used the NFI to identify and quantify
depressive symptoms of MDD  as speciﬁed in the DSM-IV.
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he lowest prevalence rate (14%) was obtained using ICD-10 crite-
ia and the highest (47%) using DSM-III criteria. Moreover, the CIs
or ICD-10, DSM-IV and DSM-III prevalence rates did not overlap,
ndicating that they yielded signiﬁcantly different rates.
As seen in Fig. 1c, a total of 10 different interview schedules were
sed to diagnose MDD/dysthymia, with the SCID-I (Nstudies = 13)
eing the most commonly used, followed by the SCAN, Mini Inter-
ational Neuropsychiatric Interview (MINI; Sheehan et al., 1998),
resent State Examination (PSE; Wing et al., 1974) and Patient
ealth Questionnaire (PHQ-9; Kroenke et al., 2001), which were
ach used by three studies. The prevalence rates obtained using
hese measures varied between 16% and 33%; although, with the
xception of the MINI and PSE, these differences were not signif-
cant. In contrast, the interviews used by single studies (e.g., CIDI,inued)
CIS, clinical diagnosis based on the Neurobehavioral Functioning
Inventory [NFI]; Kreutzer et al., 1999) yielded signiﬁcantly higher
prevalence rates (range: 42–54%) than the more commonly used
measures (i.e., SCID-I, SCAN and MINI).
Next, post-injury interval was examined to determine whether
this impacted on prevalence rates (see Fig. 1d). The mean time
intervals for the acute/post-acute, short, medium and long-term
studies were 2.4 months (SD = 1.4), 11.5 months (SD = 5), 3.1
years (SD = 0.8) and 10.5 years (SD = 6.5), respectively. Notably,
the mean prevalence of MDD/dysthymia appears to increase
in the ﬁrst 5 years after a TBI (21–43%), after which it
declines to acute/post-acute levels (22%). Moreover, the medium-
term prevalence rate was signiﬁcantly higher than any other
period.
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Although injury severity may  impact on the prevalence of
epression after a TBI, only a coarse-grained analysis of this variable
as possible because many studies used mixed samples (e.g., mild,
oderate and severe) and only provided data for the whole sample.
s seen in Fig. 1e, mild TBI was associated with a signiﬁcantly lower
revalence of MDD  and dysthymia (16%), compared with the mixed
ample category of mild, moderate and severe TBI (30%). Severe
BI was only examined by one small-scale study with a wide CI
hat overlapped with the other categories, indicating that it did not
iffer from them in terms of the prevalence of MDD/dysthymia.
Finally, data from ﬁve studies that compared the prevalence
f MDD/dysthymia in TBI and control groups were examined
Nparticipants: TBI = 600; controls = 712) (see Fig. 1f). Overall, there
as a higher prevalence of MDD/dysthymia following TBI (23%)
han in the controls (17%), with the associated OR indicating that a
erson is 1.66 times more likely than controls to develop MDD  or
ysthymia after a TBI. There was considerable variation in the ORs
or individual studies (.67–7.69), some of which may  have resulted
rom the choice of control groups. Of the ﬁve studies, four used med-
cal controls and only one used community controls. Importantly,
fter sustaining a TBI, a person is nearly eight times more likely
o develop MDD  or dysthymia (OR = 7.69) than someone from the
eneral community but only one and a half times more likely than
edical controls (OR = 1.55) (see Fig. 1g).
.3. Prevalence of clinically signiﬁcant levels of depression
‘cases’) following TBI
When the data from the 57 studies that used self-report scales to
dentify clinically signiﬁcant cases of depression following TBI were
ombined, it was found that the overall prevalence was  38% (refer to
ig. 2a ). The associated Nfs statistic was very large (Nfs = 232), indi-
ating that this is a very robust ﬁnding. As with diagnoses of MDD
nd dysthymia, there was considerable variability in the number
f cases reported by individual studies (range: 2–74%), again high-
ighting the importance of examining some of the variables that
ay  impact on these ﬁndings.
In terms of methodology, the speciﬁc self-report scale may
mpact on the prevalence of clinically signiﬁcant cases of depres-
ion (see Fig. 2b). Indeed, there was considerable variability in the
ean prevalence rates that were obtained using these different
cales, ranging from 2% for the Montgomery–Asberg Depression
ating Scale [MADRS] (Montgomery and Asberg, 1979) to 48% for
he CES-D. However, as is evident from the CIs, the prevalence rates
eported by studies using the same measure were also highly vari-
ble (e.g., BDI-II; Zung Self-rating Depression Scale [ZSDS]; Zung,
965), so much so that after excluding the MADRS, which was  only
sed by one small study, none of the other measures differed sig-
iﬁcantly; although the HADS and CES-D approached signiﬁcance.
imilarly, when studies were grouped on the basis of how they
dministered the self-report scale – by phone, in person (research
entre), by mail or using a combination of methods – there was sub-
tantial variability in the number of cases of depression reported
y studies using the same method. Interestingly, although only the
combination’ and ‘mailed’ groups differed signiﬁcantly, there was  a
rend towards fewer cases when questionnaires were administered
y phone, compared to mailed questionnaires (see Fig. 2c).
Next, the prevalence of clinically signiﬁcant cases of depression
as found to steadily increase, albeit not signiﬁcantly, as the post-
njury interval increased (see Fig. 2d), with estimates ranging from
3% in the acute/post-acute period, 35% in the short-term, 41% in
he medium term, and 42% in the longer term. Moreover, mild TBIs
ere associated with signiﬁcantly more cases of depression (64%)
han the mixed (mild/moderate/severe: 36%) and severe (39%) (see
ig. 2e) TBI samples.ehavioral Reviews 47 (2014) 1–15
Finally, the data from the 16 studies that used self-report
measures to identify cases of depression in TBI and control sam-
ples were examined (Nparticipants: TBI = 1,055; controls = 1,000) (see
Fig. 2f). The overall mean prevalence of depression following TBI
(44%) was  substantially higher than that of control groups (19%),
with the associated OR of 3.41 indicating that a person is nearly
three and a half times more likely to report clinically signiﬁcant
depression after a TBI, compared to controls. Once again, the ORs
for individual studies varied substantially (range: 1–49), raising
the possibility that the type of control group impacted on these
ﬁndings. As seen in Fig. 2g, controls from the general community
reported the lowest rates of depression (9%), followed by signiﬁ-
cant others (23%) and medical controls (36%). This was  reﬂected in
the ORs, which indicated that, following a TBI, people are nearly
six times more likely than those in the general community, three
times more likely than their signiﬁcant others (family, friends), and
over twice as likely as those with other medical conditions to expe-
rience clinically signiﬁcant levels of depression. Nevertheless, all
CIs overlapped, indicating the aforementioned differences were not
signiﬁcant.
3.4. Self-reported levels of depression: TBI vs controls
Twenty studies provided mean depression scale scores
(continuous data) for TBI and Control groups, which were exam-
ined (Nparticipants: TBI = 1,563; controls = 4,017) using Hedges g
(weighted standardised mean difference). Overall, there was a
moderate and signiﬁcant difference in the depression scores of the
TBI and control groups (Hedges g = 0.63), together with a large Nfs
statistic (Nfs = 43) (see Fig. 3a). When these studies were grouped
according to type of control group (medical/community/signiﬁcant
other), there was a large and signiﬁcant difference between the
depression scores of the TBI and community controls (see Fig. 3b).
Medical and ‘signiﬁcant other’ controls also had signiﬁcantly lower
scores than the TBI group, but these differences equated to small to
low-moderate effects.
4. Discussion
Estimates of the prevalence of depression following TBI vary
widely, limiting the clinical utility of this research. The present
study analysed the data from research that has examined the preva-
lence of MDD/dysthymia or used self-report scales to assess the
severity of depression following TBI. A variety of methodological
(diagnostic criteria, interview schedule/self-report scale, method of
administering self-report scales, control group) and patient (time
post-injury, injury severity) variables were examined to determine
whether, and to what extent, they impacted on the available ﬁnd-
ings.
Overall, the ﬁndings indicate that depression is extremely com-
mon  after a TBI, with 27% of people receiving a formal diagnosis
of MDD  or dysthymia and 38% reporting clinically signiﬁcant
symptoms on self-report scales. The lower prevalence of clinical
diagnoses is not surprising because, in addition to using more
stringent criteria, they provide a detailed assessment of the aeti-
ology and chronology of symptoms, and greater opportunities
for clariﬁcation (APA, 2000). In contrast, self-report scales mea-
sure the presence and severity of symptoms, applying a threshold
to identify clinically signiﬁcant cases; and do not provide an
opportunity to clarify whether symptoms are the result of pre-
existing (e.g., prior psychiatric history) or co-morbid conditions
(e.g., physical/cognitive consequences of a TBI), which may inﬂate
the prevalence rates (Green et al., 2001; Schwarzbold et al., 2008).
Moreover, people report more symptoms when prompted
with speciﬁc questions than when asked to freely recall them
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Fig. 2. Prevalence of clinically signiﬁcant levels of depression identiﬁed using self-report scales: (a) overall, (b) self-report scale, (c) method of administration, (d) time
post-injury, (e) injury severity, (f) overall, relative to controls, and (g) according to the type of control group. Note: CI, conﬁdence interval; Nfs, fail-safe N; MADRS,
Montgomery–Asberg Depression Rating Scale; HADS, Hospital Anxiety and Depression Scale; GDS, Geriatric Depression Scale; ZSDS, Zung Self-rating Depression Scale;
BDI,  Beck Depression Inventory; Leeds, The Leeds Scale for the Self-assessment of Anxiety and Depression; CES-D, Center for Epidemiological Scale – Depression. Refer online
Supplementary data: Table D for details of studies contributing to the summary analyses in this ﬁgure.
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Iverson et al., 2010a), also leading to higher prevalence rates.
he cognitive changes associated with TBIs (e.g., poorer memory,
mpaired insight) can, however, lead to fewer reports of depres-
ion (Wallace and Bogner, 2000); the impact of which may  be offset
y using questionnaires. Regardless of the method of assessment,
ndividuals may  exaggerate their symptoms if they are seekinginued)
ﬁnancial compensation, highlighting the importance of assessing
symptom validity when disingenuous performance may be an issue
(Whiteside et al., 2012). Once compensation claims have been set-
tled, the motivation to exaggerate symptoms is likely to reduce,
suggesting that longer-term prevalence rates are less likely to be
affected by this.
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Fig. 3. Differences in the depression scores of TBI and Control groups, as assessed by self-report scales: (a) overall and (b) according to the type of control group. Note: CI,
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Estimates of the prevalence of MDD  and/or dysthymia differed
hen different diagnostic criteria were used, with the highest rates
oted for the DSM-III (47%) and DSM-IV (25%) criteria, decreasing to
4% for the two studies that used ICD-10 criteria. These differences
re surprising, given the overlap between these criteria and the fact
hat the DSM-IV revisions were relatively conservative (First, 2010).
owever, unlike the DSM, the ICD-10 categorises symptoms into
wo groups, each of which has a diagnostic threshold; potentially
esulting in cases that meet one criterion, but not the other and
eading to fewer diagnoses (First, 2009).
Prevalence rates were also affected by the speciﬁc interview
hat was used to diagnose MDD  and dysthymia. The most com-
only used schedule – the SCID-I – yielded a prevalence rate
f 23% (Nstudies = 13), with the others ranging from 16% (MINI:
studies = 3) to 54% (CIS; Nstudies = 1). Some of this variability may
esult from the different time frames that are assessed. Indeed,
he CIS and Schedule for Affective Disorders and Schizophrenia
SADS; Endicott and Spitzer, 1978), which focus on the preced-
ng week, had the highest rates (54% and 50%, respectively).
onger time frames (previous 2 weeks to month) yielded substan-
ially lower rates (e.g., MINI = 16%; SCAN = 18%; SCID-I = 23%). Other
cales allow clinicians to select the time-frame (e.g., Diagnostic
nterview Schedule; Robins et al., 1981), but this was  often not
eported.
There was also considerable variability in the prevalence of
linically signiﬁcant cases of depression, identiﬁed on the basis ofself-report scales; with estimates ranging from 2% for the MADRS
(Nstudies = 1) to 48% for the CES-D (Nstudies = 8). Notably, the CES-D
was designed for use in the general population and incorporates
items that may  be indicative of physical or cognitive TBI symp-
toms (e.g., sleep difﬁculties, fatigue, attentional problems), possibly
inﬂating the number of ‘cases’. Interestingly, the rate obtained from
the most frequently used scale – the HADS (Nstudies = 19; 32%) – was
substantially lower than the ﬁnding for the CES-D (48%). The HADS
was speciﬁcally designed for use in medical settings and, conse-
quently, does not include items that may  reﬂect the physical, rather
than psychological, consequences of a TBI (Zigmond and Snaith,
1983). This measure may  therefore provide the best estimate of
self-reported cases of depression.
The prevalence of self-reported ‘cases’ of depression also dif-
fered according to how the scale was  administered. Speciﬁcally,
more cases were identiﬁed when people completed questionnaires
at home and returned them by mail (46%), than when completed
by phone interview (26%). Phone administration may  encourage
people to respond in a socially-desirable manner, possibly causing
them to down-play their symptoms and/or provide limited oppor-
tunity to reﬂect on and revise their answers (Aziz and Kenford,
2004; Fairweather-Schmidt and Anstey, 2012). However, at home,
a person may  be inﬂuenced by others, even when there are explicit
instructions stating that all responses must be their own  and/or no
discussion with others is permitted (Alfano et al., 1993; O’Carroll
et al., 1991).
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In addition, prevalence rates varied according to the post-injury
nterval, with the prevalence of MDD/dysthymia steadily increasing
n the ﬁrst 5 years post-TBI (21–27–43%) and subsequently declin-
ng to a level similar to that seen in the early post-injury period
22%). In contrast, the number of ‘cases’ of depression identiﬁed
sing questionnaires steadily increased – although not signiﬁ-
antly – from the acute/post-acute period until the medium-term
33–41%), when it plateaued. These ﬁndings highlight temporal
hanges to the risk of developing depression, possibly reﬂecting
he changing inﬂuence of a number of different variables (e.g., neu-
onal/neurochemical, psychological, social). They also underscore
he importance of monitoring individuals over an extended period
f time and providing ongoing access to mental health support
ervices.
Unfortunately, injury severity could only be examined in a
asic way, due to the limited availability of data. These analyses
evealed that mild TBI was associated with the lowest prevalence
f MDD  and dysthymia (16%); a rate that was signiﬁcantly lower
han that seen in mixed samples (30%). Although lower than the
ate for severe TBI (30%), this difference was not signiﬁcant, pos-
ibly due to the small sample size. These ﬁndings contrasted with
hose from self-report measures, which revealed signiﬁcantly more
ases of depression following mild TBI (64%) (mixed samples = 36%;
evere TBI = 39%). There are a number of factors that may  con-
ribute to the latter ﬁnding. For example, severe TBIs are more
requently associated with memory problems and impaired self-
wareness (Evans et al., 2005), which may  reduce the number
f symptoms that are endorsed on questionnaires (Malec et al.,
007). Alternatively, persons with mild TBI may  be exaggerating
heir symptoms for ﬁnancial gain (Kurtz et al., 2007). However,
t is also possible that people do not receive adequate psycho-
ducational support following a mild TBI, which may  increase their
istress or, in the absence of signiﬁcant physical injuries, they may
ocus on other problems (Malec et al., 2007). Therefore, even fol-
owing mild TBI, individuals should be monitored to ensure that
hese symptoms do not interfere with their recovery or quality of
ife.
Relative to others, people are more likely to be diagnosed with
DD/dysthymia (OR = 1.66), or experience clinically signiﬁcant
evels of depression (OR = 3.41) following a TBI. Even when con-
ributing factors, such as pain and hospital/medical procedures, are
aken into account, a TBI provides an additional, unique source of
sychological distress. Similarly, TBI groups were nearly eight times
ore likely to be diagnosed with MDD/dysthymia, and over ﬁve
imes more likely to be classiﬁed as having clinically signiﬁcant lev-
ls of depression, than members of the general community. Lastly,
he family/friends/caregivers of those who have sustained a TBI
eported suffering from high levels of depression (23%), indicating
hat they are also at considerable risk of developing depression, and
ay  require monitoring and treatment to optimise their outcomes
Ergh et al., 2002; Ponsford et al., 2010).
Finally, when the full spectrum of self-reported depressive
ymptoms was examined – ranging from normal to severe depres-
ion – it was found that individuals experienced moderately higher
evels of depression following a TBI than their peers. This ﬁnding
as impacted by the source of the controls, with the largest differ-
nce associated with people residing in the community, followed
y signiﬁcant others and then medical controls. This highlights
he importance of selecting the appropriate norms or controls,
ased on the clinical or research question, to enable depression
o be examined independently of a range of confounding variables.
peciﬁcally, medical controls endeavour to control for pain, other
njuries and hospital routines/procedures (Ponsford et al., 2011);
igniﬁcant others control for the increased levels of stress and
motional distress related to a family member’s TBI (Ponsford and
chönberger, 2010); and community controls enable an assessmentehavioral Reviews 47 (2014) 1–15
of depression relative to people who  are residing in the general
community (Wacholder et al., 1992).
4.1. Limitations and recommendations for future research
There are a number of limitations that warrant consideration.
First, although prior TBIs and psychiatric history may contribute
to the development of depression (Anstey et al., 2004; Fann et al.,
2002), these data were often not reported, or provided in a form
that could not be compared (e.g., no major psychiatric illness, no
prior hospitalisation, not currently using medication); precluding
an analysis of these variables. Second, data were often combined
across different injury categories (mild, moderate, severe), which
meant that it was only possible to undertake a coarse-grained
examination of TBI severity. Third, it was  not possible to examine
the impact of medications on the prevalence of depression because
very few studies reported these data. Anti-depressant medications
are likely to reduce symptoms and result in lower prevalence esti-
mates, making this an important variable to consider. Fourth, it
is possible that gender may  have impacted on the prevalence of
depression following TBI because females have a higher risk of
developing depression (Kessler et al., 1993), although males are
more likely to sustain a TBI (Anstey et al., 2004). Of the studies
that reported the prevalence of MDD/dysthymia, only six provided
gender-based data. While there was  a trend for females to have
higher rates of MDD/dysthymia in these studies (47% vs 34%), the
difference was not signiﬁcant.
It is recommended that researchers report participants’ history
of TBIs/psychiatric diagnoses and, ideally, provide subgroup data
(mild/moderate/severe TBI; medicated vs unmedicated; males vs
females), so that these variables can be examined in greater detail.
Multivariate analyses of the data were not possible due to the vari-
ability in the research designs that have been used to examine the
prevalence of depression following TBI. A large-scale study that
evaluates the impact of these variables is now needed.
5. Conclusions
There is now a substantial body of research that has exam-
ined the prevalence of depression following TBI, but the estimates
from individual studies vary widely. The challenges involved
in interpreting these disparate ﬁndings are well-known, with
researchers repeatedly noting that numerous methodological dif-
ferences have made it difﬁcult to compare ﬁndings and draw
deﬁnitive conclusions (Koponen et al., 2011; Tsaousides et al., 2013;
Whelan-Goodinson et al., 2009a).
Overall, the prevalence of formally diagnosed MDD  and dys-
thymia was  27%, although this varied depending on whether ICD-10
(14%), DSM-IV (25%) or DSM-III (47%) diagnostic criteria were used.
The different interview schedules also yielded variable prevalence
rates, ranging from 16% to 54%. MDD/dysthymia was more preva-
lent between 2 and 5 years post-injury (43%), compared with the
acute/post-acute period (<6 months; 21%), short-term (≥6 months
to <2 years; 27%), and long-term (≥5 years; 22%). In addition, the
prevalence of MDD/dysthymia was  substantially higher following
severe TBI (30%) than mild TBI (16%), although this difference was
not signiﬁcant. Moreover, MDD/dysthymia is more common fol-
lowing TBI than it is after other injuries (OR  = 1.55) and in the
general community (OR = 7.69).
The overall prevalence of clinically signiﬁcant ‘cases’ of depres-
sion, assessed using questionnaires, was  38%; although this rate
varied considerably depending on the measure that was  used
(2–48%) and the method of administration (phone: 26%; mail: 46%).
Unlike MDD  and dysthymia, self-reported depression continued to
increase over time (from 33% to 42%) and injury severity had a
paradoxical effect, with more cases of depression following mild
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BI (64%, severe TBI = 39%). The odds of developing depression after
 TBI are more than ﬁve, three and two times higher than those liv-
ng in the general community, the family and friends of the person
ho sustained the TBI, and other medical patients, respectively.
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Supplementary data associated with this article can be found,
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